Clinical results of and prospects for the use of controlled-release antiepileptic drugs: a new once-daily levetiracetam formulation

Clinical results of and prospects for the use of controlled-release antiepileptic drugs: a new once-daily levetiracetam formulation

Many antiepileptic drugs (AEDs) have a short half-life (T1/2) with a wide fluctuation from peak to trough blood concentrations. According to this pharmacokinetic profile, there may be both adverse events (AEs) due to the increase in a blood drug concentrations and seizures as a result of its fall, w...

Full description

Bibliographic Details
Main Author: P. N. Vlasov
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2017-11-01
Series:Nevrologiâ, Nejropsihiatriâ, Psihosomatika
Subjects:
epilepsy
antiepileptic drugs
pharmacokinetics
efficacy
tolerability
adverse events
therapy adherence
levetiracetam
Online Access:https://nnp.ima-press.net/nnp/article/view/780

Internet

https://nnp.ima-press.net/nnp/article/view/780

Similar Items